Keywords: s-p, chooses, corvas, thrombin, inhibitor, collaboration, schering-plough
S-P Chooses Corvas' Thrombin Inhibitor In Collaboration
Article | 13 January 1997
- Schering-Plough has selected one of Corvas International's oralthrombin inhibitors to develop as a treatment for chronic diseases caused by thrombosis. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
